ReviewFrontiers in oncology2022

Muramyl dipeptide-based analogs as potential anticancer compounds: Strategies to improve selectivity, biocompatibility, and efficiency.

Eliza Iwicka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.